According to the BBC and other media reported on the 14th, a needleless aero-new crown vaccine developed by the University of Cambridge in the United Kingdom and the British biotechnology company DIOSYnVax opened clinical trials on Tuesday (14th). The researchers said the vaccine could provide "broad protection" against future variants of the new coronavirus.
UK opens clinical trials for a needle-free COVID-19 vaccine BBC chart
Sprayed by air
The vaccine, called DIOS-CoVax, was developed in collaboration with the R&D team of Professor Jonathan Heaney of the University of Cambridge and CEO of DIOSYnVax. On Tuesday, subjects between the ages of 18 and 50 will undergo clinical trials at the National Institutes of Health's Southampton Clinical Research Facility. It is reported that the DIOS-CoVax vaccine is known as the next generation of new crown virus vaccine, it will be administered through air spray, delivering the vaccine to the skin.
A "innovative" vaccine
Heaney said the vaccine his team developed was "innovative." "As new variants emerge and immunity begins to wane, we need newer technologies," he said. He said the DIOS-CoVax vaccine uses different techniques to fight disease, which could provide broader protection against variants of the coronavirus and other coronaviruses. Current COVID-19 vaccines use genes extracted from viral spike proteins to encode antigens, allowing the immune system to produce antibodies. While the DIOS-CoVax vaccine uses predictive methods to mimic a broader family of coronavirus antigens, the researchers hope these antigens will provide more protection.
The vaccine offers a possible future alternative for people who are afraid of needles. In addition, it can also be freeze-dried, making it easier to store. "These next-generation vaccines should protect us against the mutated viruses we've seen so far, such as alpha, beta, delta variants, and hopefully give us protection against emerging variants and potential coronavirus pandemics in the future," Heini said. ”
Upstream News Compiled by Jiang Mingjing
![Reducing COVID-19 infections and getting colds really helps! The new study provides the clearest evidence to date[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)